This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
27-29 April 2027
Congress Center HamburgHamburg, Germany
Book Now
Menu
Book Now
keyboard_arrow_right

Pre-Con Workshop Day (27th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)

keyboard_arrow_leftSearch & Filter
search
Pre-Con Workshop Day (27th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)
search
Showing 1 of 1 Streams
09:00 - 10:30
Section 1: CMC and the Development Cycle

1.1 Introduction to Drug Regulation

1.2 The Drug Development Cycle

1.3 Quality by Design

  • Margit Holzer - Scientific Director, Ulysse Consult
  • Thomas Chattaway - Senior Life Science Consultant, Independent
Showing 1 of 1 Streams
11:00 - 11:30
Section 1: CMC and the Development Cycle

1.4 Guidance

  • Margit Holzer - Scientific Director, Ulysse Consult
  • Thomas Chattaway - Senior Life Science Consultant, Independent
11:30 - 12:00
Section 1: Q&A and Quiz
  • Margit Holzer - Scientific Director, Ulysse Consult
  • Thomas Chattaway - Senior Life Science Consultant, Independent
Showing 1 of 1 Streams
13:00 - 14:30
Section 2: CMC Activites from Pre-Clinical to Phase 2

2.1 First Overview

2.2 Dealing with Changes

2.3 Control of Adventitious Agents

2.4 Cell Banks and Raw Materials

  • Margit Holzer - Scientific Director, Ulysse Consult
  • Thomas Chattaway - Senior Life Science Consultant, Independent
Showing 1 of 1 Streams
14:30 - 16:00
Section 2: CMC Activites from Pre-Clinical to Phase 2

2.5 Process Development and Design

2.6 Development of Analytical Methods

2.7 Formulation and Stability

  • Thomas Chattaway - Senior Life Science Consultant, Independent
  • Margit Holzer - Scientific Director, Ulysse Consult
16:00 - 16:30
Section 3: Moving Forward and Conclusions

3.1 What happens after Phase 2?

3.2 Q&A and Conclusions

  • Thomas Chattaway - Senior Life Science Consultant, Independent
  • Margit Holzer - Scientific Director, Ulysse Consult
NextMain Conference Day 1 (28th April 2026)
Filter
Streams
Clear
Choose Day